There are bipartisan solutions to lower drug prices, including H.R. 19, the Lower Costs, More Cures Act.
James Guthrie
The Public Record
Developing therapies will not happen unless we somehow find a way to incentivize our partners in the pharmaceutical industry.
I challenge my colleagues: Would you still agree with this statement, knowing that one of those forfeitures could have been the COVID-19 vaccine?
We know the American people want lower prices. But they do not want to sacrifice access to life-changing treatment.
If we are going to do the right thing, even when we disagree, let's at least do the constitutional.
I am very concerned about the consequences of Speaker Pelosi's partisan drug bill, H.R. 3, that is before us today.
Under H.R. 3, we would be forced to sacrifice this access for bureaucracy and fewer cures.
I remain concerned that the bill currently does nothing to resolve potential First Amendment issues.





